ESEkaterina N. Serhiyenka

Ekaterina N. Serhiyenka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina N. Serhiyenka has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Markers of poor prognosis in meningococcal sepsis

    by K.N. Serhiyenka

    Background. Neisseria meningitidis (meningococcus) is a highly fatal disease worldwide, occurring in epidemic and sporadic cases. The virulence of invasive N. meningitidis is determined by several key factors, including surface adhesins (pili), a protective capsule, and endotoxin release (lipid A from lipooligosaccharides). Furthermore, the bacterium has evolved genetic adaptations, including horizontal gene transfer, antigenic variation, and molecular mimicry, which allow it to successfully colonize mucosal surfaces, invade the bloodstream, and evade the immune system. The acquisition of N. meningitidis typically occurs through exposure to respiratory droplets. Meningococcal infection can present in both localized (nasopharyngitis, carriage) and generalized forms (meningitis, meningococcal bloodstream infection, meningoencephalitis, and mixed forms). Atypical presentations also include: arthritis, myocarditis, iridocyclitis, and others. The clinical form of infection is a key determinant of the outcome, the spectrum of potential complications and long-term sequelae, accounting for approximately 20-30% of cases. The epidemiology of N. meningitidis is variable and unpredictable. Early clinical symptoms are nonspecific and can lead to misdiagnosis and, therefore, delayed optimal treatment. Objective. To analyze clinical and laboratory data to identify the clinical features and markers of adverse events in meningococcal sepsis (meningococcemia). Materials and methods. We analyzed the records of inpatients under 18 years of age treated for meningococcemia (meningococcal sepsis) at the Minsk City Children's Infectious Diseases Clinical Hospital from 2009 to 2024. Results. The main clinical manifestations of meningococcal sepsis are febrile fever (98.1-100%) and rash (100%). Meningococcemia most often occurs in combination with nervous system damage and the development of meningitis/meningoencephalitis (53.2-69.3%). The development of Waterhouse-Friderichsen syndrome in meningococcal sepsis increases the risk of death by almost 9 times. Conclusion. Established markers of an unfavorable course of meningococcal sepsis include septic shock and Waterhouse-Friderichsen syndrome.

  • Open Access

    Prediction models for the course of sepsis in children

    by Ekaterina N. Serhiyenka, O. V. Krasko, O. N. Romanova

    Sepsis is a pathological process in which, uncontrolled as a result of dysregulation, the body’s immune response to infection leads to organ failure that threatens the patient’s life. The development of septic shock aggravates the course of sepsis and significantly affects the outcome of the pathological process. Therefore, the development of prognostic tools (markers, models, algorithms) is an important component in the treatment of patients with sepsis. Objectives. To develop models capable of predicting the likelihood of septic shock and death in patients based on a combination of identified prognostic factors. Materials. To identify factors predisposing to the development of septic shock, 2 groups of patients were formed: the 1st group (109 people) included patients with sepsis without the development of shock, and the 2nd group (72 people) - patients in whom sepsis progressed to septic shock. Similarly, to determine predictors of death, groups of patients with a favorable (129 people) and unfavorable (fatal, 49 people) outcome were formed. Results. The analysis identified factors associated with the development of septic shock: urea, OR 2.3 (1.1-4.7), p = 0.026; APTT, OR 4.3 (1.4-16), p = 0.017; lactate, OR 2.4 (1.2-5), p = 0.02; protein, OR 1.3 (0.6-3), p = 0.475. Factors associated with death were established: CRP, AUC 0.69 (0.60-0.78); lactate, AUC 0.72 (0.63-0.82); fibrinogen A, AUC 0.69 (0.59-0.78); Pelod-2 scores, AUC 0.77 (0.69 -0.85); pSofa, AUC 0,72 (0,63-0,81); Phoenix, AUC 0,80 (0,71-0,88); Prism, AUC 0.70 (0.61-0.79) and sum of organ deficiencies, AUC 0.82 (0.74-0.88). Conclusions. The presented models for predicting the development of septic shock and adverse outcomes in sepsis are accessible and easy to use.

  • Open Access

    THE ECONOMIC BURDEN OF INVASIVE FORMS OF MENINGOCOCCAL INFECTION

    by E.N. Sergienko, I.N. Kozhanova, O.N. Romanova, A.D. Solodov, P.A. Scutova

    Relevance Invasive meningococcal infection (IMI) is a significant clinical problem and is associated with a high probability of severe complications and death. Vaccination programs against meningococcus can achieve significant clinical effectiveness and require significant financial costs. This makes it relevant to study the economic burden of meningococcal infection in the conditions of modern healthcare in order to obtain basic data for subsequent research in the field of evaluation of medical technologies. Aims To assess the economic burden of IMI in children in the conditions of healthcare in the Republic of Belarus. Material and methods a retrospective study using the “cost of illness” method was conducted for 22 children hospitalized in the city children’s infectious clinical diseases hospital in 2018-2019. All values are presented in belarusian rubles. The average ± standard deviation, minimum – maximum values, median [Q1, Q3], cost shares (%) are calculated for the cost values. The minimum– maximum values and median [Q1, Q3] were calculated for the age of the patients. Results taking into account the costs of treatment in healthcare organizations of all patients studied, the share of direct costs of hospitalization was 29.0%, the share of direct costs of diagnosis - 7.2%, the share of direct costs of pharmacotherapy - 8.3%. A significant part of the costs accounted for observations after discharge and amounted to 55.4%. Conclusion a retrospective study of the economic burden of MI in the Republic of Belarus using the “cost of illness” method in patients hospitalized in a public health organization demonstrates a significant economic burden of this disease, which in the long term is primarily due to the presence of complications in the patient, as well as the impact of the patient’s death on the value of total costs.

  • Open Access

    Economic Burden of Invasive Meningococcal Infection in Children in the Republic of Belarus

    by E. N. Sergienko, I. N. Kozhanova, O. N. Romanova, A. D. Solodov, P. A. Sсutova

    Relevance Invasive meningococcal infection (IMI) is a significant clinical problem and is associated with a high probability of severe complications and death. Vaccination programs against meningococcus can achieve significant clinical effectiveness and require significant financial costs. This makes it relevant to study the economic burden of meningococcal infection in the conditions of modern healthcare in order to obtain basic data for subsequent research in the field of evaluation of medical technologies.Aims. To assess the economic burden of IMI in children in the conditions of healthcare in the Republic of BelarusMaterial and methods: a retrospective study using the "cost of illness" method was conducted for 22 children hospitalized in the city children's infectious clinical diseases hospital in 2018-2019. All values are presented in belarusian rubles. The average ± standard deviation, minimum – maximum values, median [Q1, Q3], cost shares (%) are calculated for the cost values. The minimum– maximum values and median [Q1, Q3] were calculated for the age of the patients.Results: taking into account the costs of treatment in healthcare organizations of all patients studied, the share of direct costs of hospitalization was 29.0%, the share of direct costs of diagnosis – 7.2%, the share of direct costs of pharmacotherapy - 8.3%. A significant part of the costs accounted for observations after discharge and amounted to 55.4%.Conclusion: a retrospective study of the economic burden of MI in the Republic of Belarus using the "cost of illness" method in patients hospitalized in a public health organization demonstrates a significant economic burden of this disease, which in the long term is primarily due to the presence of complications in the patient, as well as the impact of the patient's death on the value of total costs. The data obtained can be used in conducting national research on the evaluation of medical technologies.